These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32612144)

  • 1. Real-world characterization of blood glucose control and insulin use in the intensive care unit.
    Baker L; Maley JH; Arévalo A; DeMichele F; Mateo-Collado R; Finkelstein S; Celi LA
    Sci Rep; 2020 Jul; 10(1):10718. PubMed ID: 32612144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefits of tight glycaemic control: focus on the intensive care unit.
    Mesotten D; Van den Berghe G
    Best Pract Res Clin Anaesthesiol; 2009 Dec; 23(4):421-9. PubMed ID: 20108581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive insulin therapy in the critically ill geriatric patient.
    Humbert J; Gallagher K; Gabbay R; Dellasega C
    Crit Care Nurs Q; 2008; 31(1):14-8. PubMed ID: 18316931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Accurate Point-of-Care Glucose Monitoring for Tight Glycemic Control in Severely Burned Children.
    Tran NK; Godwin ZR; Steele AN; Wolf SE; Palmieri TL
    Pediatr Crit Care Med; 2016 Sep; 17(9):e406-12. PubMed ID: 27472251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriateness of action prompts for hypoglycaemia and hyperglycaemia in type 2 diabetes self-management apps.
    Lum E; Jimenez G; Huang Z; Thai L; Car J
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3235. PubMed ID: 31721421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
    Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
    Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood glucose control in the intensive care unit: benefits and risks.
    Gunst J; Van den Berghe G
    Semin Dial; 2010; 23(2):157-62. PubMed ID: 20525106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.
    Umpierrez GE; O'Neal D; DiGenio A; Goldenberg R; Hernandez-Triana E; Lin J; Park CY; Renard E; Kovatchev B
    Diabetes Obes Metab; 2017 Sep; 19(9):1317-1321. PubMed ID: 28256054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of intensive glycaemic control into a neurosurgical intensive care unit: a retrospective cohort study.
    Wittenberg MD; Gattas DJ; Ryan A; Totaro R
    Crit Care Resusc; 2008 Sep; 10(3):203-8. PubMed ID: 18798718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes.
    Balintescu A; Mårtensson J
    Crit Care Clin; 2019 Apr; 35(2):289-300. PubMed ID: 30784610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in non-diabetic critically ill patients.
    Farrokhi F; Smiley D; Umpierrez GE
    Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):813-24. PubMed ID: 21925080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing glucose control protocols in critically ill patients.
    Susla GM
    AACN Adv Crit Care; 2007; 18(1):5-9. PubMed ID: 17284942
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycemic control in the intensive care unit: between safety and benefit.
    Samokhvalov A; Farah R; Makhoul N
    Isr Med Assoc J; 2012 Apr; 14(4):260-6. PubMed ID: 22675848
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycaemic control and prediction of ICU stay.
    Fallaha D; Cuthbertson BH
    Resuscitation; 2007 Nov; 75(2):389-90. PubMed ID: 17618032
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients.
    Doola R; Greer RM; Hurford R; Flatley C; Forbes JM; Todd AS; Joyce CJ; Sturgess DJ
    Clin Nutr; 2019 Aug; 38(4):1707-1712. PubMed ID: 30170779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of metformin and insulin in the control of hyperglycaemia in non-diabetic critically ill patients.
    Mojtahedzadeh M; Jafarieh A; Najafi A; Khajavi MR; Khalili N
    Endokrynol Pol; 2012; 63(3):206-11. PubMed ID: 22744627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial.
    Chon S; Rhee SY; Ahn KJ; Baik SH; Park Y; Nam MS; Lee KW; Yoo SJ; Koh G; Lee DH; Kim YS; Woo JT;
    Diabetes Obes Metab; 2018 May; 20(5):1121-1130. PubMed ID: 29272062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.